Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04510376 · ClinicalTrials.gov registry record · NA
Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method
A NA study, sponsored by Omeza.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04510376: Completed NA study, sponsored by Omeza.
NCT04510376 is a NA study that has completed, run by Omeza. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04510376, a NA study, has completed, sponsored by Omeza.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Single-center, monadic, one day study utilizing the skin prick method to assess the allergy potential of Omeza Collagen Matrix in Human Subjects
Primary Outcome
Response of at least 3-mm diameter (with equivalent erythema) more than negative control is required as proof of presence of cutaneous allergen specific IgE
Interventions
- OTHER Negative Control
- OTHER Positive Control
- DEVICE Test Article
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-11-14 |
| Est. Completion | 2019-11-14 |
| Phase | NA |
What the finished NCT04510376 record still lists
NCT04510376 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Negative Control is the first listed.
NCT04510376 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04510376 about?
NCT04510376 is a clinical study titled "Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method". Single-center, monadic, one day study utilizing the skin prick method to assess the allergy potential of Omeza Collagen Matrix in Human Subjects
What is the current status of trial NCT04510376?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-11-14. Estimated completion is 2019-11-14.
What interventions are being tested in trial NCT04510376?
The interventions under investigation include: Negative Control (OTHER), Positive Control (OTHER), Test Article (DEVICE).
Who is sponsoring clinical trial NCT04510376?
This trial is sponsored by Omeza, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04510376's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI